Prasco has ascended to the leadership position in Authorized Generics. As one of the fastest growing pharmaceutical companies in the industry, Prasco has successfully launched the largest number of Authorized Generics in the industry. Using its unique background and experience in both the branded and generic businesses, Prasco has developed a business model that allows pharmaceutical companies to optimally extend the lifecycle of select branded products faced with current or near-term generic competition. This model calls for Prasco to market those products as Prasco Authorized Generics under the Prasco label, and share profits with the brand company. Prasco’s advantage is the completeness of the company’s approach to its partnerships and relationships. To best execute these relationships, Prasco has constructed a tightly-knit, team-based infrastructure to minimize the amount of partner management time and resources to implement the plan. The Spectrum Approach
Prasco considers participants in its Authorized Generic program as partners in the truest sense – for Prasco, unlike other generic companies, is not structured to compete with brand companies; instead, its focus is on providing Pharma companies access into the generic marketplace with their products. Prasco leadership is comprised of PhRMA (Pharmaceutical Research and Manufacturers of America) trained executives and those with considerable generic industry success. Therefore, Prasco fully understands the Pharma dilemma (generic competition) and the Pharma solution (product lifecycle extension through the generic marketplace). Lifecycle Extension/Authorized Generics are an important part of the pharmaceutical industry. Prasco is at the forefront leading the efforts to protect the interests of its partners, and to ensure consumers have access to a free and competitive marketplace. For more information on our government affairs activities, visit Government Affairs.
> Learn about Partnership Opportunities
> Visit www.authorizedgenerics.com
| 
